Legacy Pharmaceuticals Private Limited, a active private limited company, was established on 29 January 2016 in Pune, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24290PN2016PTC158159. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Employing 29 professional, Its leadership includes Dhananjay Dattatray Kulkarni (Additional Director), Ram Appasaheb Magar (Additional Director), Nilesh Sharadrao Aparajit (Director). Past directors included Madhuri Santosh Jagtap, Ashok Gaikwad Madhav, Santosh Ankush Pathare. It holds ₹1.50 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at S No 166, Gajanan Nagar Phursungi, Pune, Maharashtra, 412307.
U24290PN2016PTC158159
158159
29 January 2016
₹0.50 M
₹0.10 M
Roc Pune
Unlisted
Active
Explore comprehensive insights into Legacy Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Dhananjay Dattatray Kulkarni | Additional Director | 10 Jun 2021 | Current |
| Ram Appasaheb Magar | Additional Director | 20 Sep 2024 | Current |
| Nilesh Sharadrao Aparajit | Director | 29 Jan 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 27 Dec 2020 | Past |
| Pramod Abcsdd | Additional Director | 30 Dec 2017 | Past |
| Pramod Abcsdd | Additional Director | 30 Dec 2017 | Past |
| Pramod Abcsdd | Additional Director | 30 Dec 2017 | Past |
| Pramod Abcsdd | Additional Director | 25 Mar 2024 | Past |
| Pramod Abcsdd | Additional Director | 30 Dec 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Legacy Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 10.94% decrease. The company also saw a substantial improvement in profitability, with a 24.81% increase in profit. The company's net worth Soared by an impressive increase of 32.46%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Legacy Pharmaceuticals had a promoter holding of 51.00% and a public holding of 49.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹15,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Sep 2024 | Others | ₹1.50 Cr | Open |
Explore comprehensive loan charge details -
Legacy Pharmaceuticals has a workforce of 29 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Legacy Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Legacy Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Legacy Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Ram Appasaheb Magar was appointed as a Additional Director was appointed as a Additional Director on 20 Sep 2024 & has been associated with this company since 1 year 2 months . was completed.
The activity A charge with Others amounted to Rs. 15.00 M with Charge ID 100979576 was registered on 04 Sep 2024. was completed.
Progress on Legacy Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune. was documented.
The activity Dhananjay Dattatray Kulkarni was appointed as a Additional Director was appointed as a Additional Director on 10 Jun 2021 & has been associated with this company since 4 years 5 months . was completed.
Progress on Nilesh Sharadrao Aparajit was appointed as a Director was appointed as a Director on 29 Jan 2016 & has been associated with this company since 9 years 10 months . was documented.
The CIN of Legacy Pharmaceuticals Private Limited is U24290PN2016PTC158159.
Legacy Pharmaceuticals Private Limited is headquartered at S No 166, Gajanan Nagar Phursungi, Pune, Maharashtra, 412307.
Legacy Pharmaceuticals Private Limited was incorporated on 29 January 2016.
The current directors of Legacy Pharmaceuticals Private Limited are
The primary industry of Legacy Pharmaceuticals Private Limited is Trade.
Legacy Pharmaceuticals Private Limited is unlisted.
The authorized capital of Legacy Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.
The compliance status of Legacy Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX